MH
Elite in Leiomyosarcoma
Check Dr. Martee L. Hensley's experience treating your condition:
About Dr. Martee L. Hensley

Martee Hensley is an Oncologist in New York, New York. Hensley has been practicing medicine for over 34 years and is rated as an Elite expert by MediFind in the treatment of Leiomyosarcoma. She is also highly rated in 18 other conditions, according to our data. Her top areas of expertise are Leiomyosarcoma, Endometrial Cancer, Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, and Salpingo-Oophorectomy. She is licensed to treat patients in New York. Hensley is currently accepting new patients.

Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, she has co-authored 40 articles and participated in 7 clinical trials in the study of Leiomyosarcoma.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Martee L. Hensley it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
16 E 60th St, New York, NY 10022
Background & Education
Graduate Institution
New York Medical College, 1989
Specialties
Oncology
Licenses
Internal Medicine in NY
Hospital Affiliations
Memorial Sloan Kettering Cancer Center
Shore Medical Center
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Phase II Evaluation of Docetaxel and Gemcitabine Plus G-CSF in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus
Adjuvant Treatment of High Risk Uterine Leiomyosarcoma With Gemcitabine/Docetaxel Followed by Doxorubicin: A Phase II Trial
A Multi-Center Phase II Study of the Halichondrin B Analog E7389 in Recurrent Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
A Pilot Study of Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
View 6 Less Clinical Trials -

109 Total Publications

Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Elite